EORTC protocol 06031 - AML-19

Gemtuzumab ozogamicin (GO) monotherapy versus standard supportive care for previously untreated AML in elderly patients who are not eligible for intensive chemotherapy : a randomized phase II/III trial (AML-19) of the EORTC-LG and GIMEMA-ALWP.
Trial StatusRecruiting
DatesDate of activation: 28-Jun-04
Data management at EORTCFull
Phase2-3
Randomized trialYes
TypeHemato-malign
Targeted Sample sizeEORTC Groups: 75 - All Groups: 267
Number of steps1
DrugGemtuzumab
Study StaffSergio Amadori (Study Coordinator) - Azienda Ospedallera Universitaria - Policlinico Tor Vergata, Roma
Stefan Suciu (Statistician) - EORTC Headquarters, Brussels
Séraphine Rossi (Data Manager) - EORTC Headquarters, Brussels
Safaa Ramadan (Coordinating Physician) - EORTC Headquarters, Brussels
Hilde Breyssens (Project Manager) - EORTC Headquarters, Brussels, hilde.breyssens( at )eortc.be, +32 27741004
Type of cancerAcute Myelogenous Leukemia
Participating GroupsEORTC Leukemia Group(Coordinating Group)
Gruppo Italiano Malattie Ematologiche dell'Adulto
Centers authorized by EORTC Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101
A.Z. St. Jan (Brugge, Belgium) - Inst. 109
ZNA Middelheim (Antwerpen, Belgium) - Inst. 114
Universitair Ziekenhuis Antwerpen (Edegem, Belgium) - Inst. 117
Centre Hospitalier Peltzer-La Tourelle (Verviers, Belgium) - Inst. 118
Hôpitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme (Brussels, Belgium) - Inst. 131
C.H.U. Sart-Tilman (Liege, Belgium) - Inst. 155
Amedeo Avogadro University of Eastern Piedmont-Ospedale Maggiore della Carita (Novara, Italy) - Inst. 9006
Ospedale Castelfranco Veneto (Castelfranco Veneto, Italy) - Inst. 166
Ospedale San Eugenio (Roma, Italy) - Inst. 692
Azienda Ospedaliera Di Parma (Parma, Italy) - Inst. 696
Ospedale Sta Maria Delle Croci (Ravenna, Italy) - Inst. 701
Ospedale Maggiore (Trieste, Italy) - Inst. 716
Ospedale S. Donato, USL -8 (Arezzo Cap, Italy) - Inst. 3936
Universita Di Roma La Sapienza - Universita Degli Studi Di Roma La Sapienza - Ospedale Sant'Andrea (Roma, Italy) - Inst. 3944
Asl8 - Ospedale R. Binaghi (Cagliari, Italy) - Inst. 8968
Azienda Ospedaliera Vito Fazzi (Lecce, Italy) - Inst. 9039
Libero Istituto Universitario Campus Bio-Medico (Roma, Italy) - Inst. 3903
H. San Giovanni - Addolorata (Roma, Italy) - Inst. 3904
Universita Degli Studi Di Siena -Policlinico "le Scotte" (Siena, Italy) - Inst. 3922
La Maddalena S.P.A. (Palermo, Italy) - Inst. 3923
Azienda Ospedallera Universitaria - Policlinico Tor Vergata (Roma, Italy) - Inst. 3931
Ospedale Civile Umberto I (Nocera Inferiore, Italy) - Inst. 3934
Ospedale San Carlo (Potenza, Italy) - Inst. 819
Ospedale A. Cardarelli (Napoli, Italy) - Inst. 820
Universita Di Modena e Reggio Emilia C.O.M. - Centro Oncologico Modenese (Modena, Italy) - Inst. 825
Istituto Di Ematologia - Universita Di Sassari (Sassari, Italy) - Inst. 828
Universita Di Ferrara - Ospedale S. Anna (Ferrara, Italy) - Inst. 3875
Ospedale Di Montefiascone (Montefiascone, Italy) - Inst. 3896
Universita Degli Studi Di Bari - Policlinico (Bari, Italy) - Inst. 793
Ospedale Regionale A. Pugliese (Catanzaro, Italy) - Inst. 794
Ospedale Ferrarotto (Catania, Italy) - Inst. 799
Ospedale Oncologico A. Businco (Cagliari, Italy) - Inst. 814
Ospedale Civile Pescara (Pescara, Italy) - Inst. 816
Policlinico P. Giaccone - Universita Di Palermo (Palermo, Italy) - Inst. 818
Universita Di Roma La Sapienza - Clinica Ematologica dell'Università di Roma "La Sapienza" (Roma, Italy) - Inst. 733
Universita Di Brescia (Brescia, Italy) - Inst. 741
Istituto Regina Elena (Roma, Italy) - Inst. 742
Policlinico Monteluce (Perugia, Italy) - Inst. 744
Policlinico Universitario A. Gemelli - Universita Del Sacro Cuore (Roma, Italy) - Inst. 777
Ospedale San Salvatore (Pesaro, Italy) - Inst. 792
Jeroen Bosch Ziekenhuis ('s-Hertogenbosch, The Netherlands) - Inst. 22
Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304
Onze Lieve Vrouw Gasthuis (Amsterdam, The Netherlands) - Inst. 309
Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00091234
EudraCT2004-004356-39
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section